Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Gastric Cancer

Free Subscription Articles published in Br J Cancer Retrieve available abstracts of 27 articles: HTML format Text format

Single Articles

July 2018
1. KNODLER M, Korfer J, Kunzmann V, Trojan J, et al
   Randomised phase II trial to investigate catumaxomab (anti-EpCAM x anti-CD3) for treatment of peritoneal carcinomatosis in patients with gastric cancer.
   Br J Cancer. 2018 Jul 10. pii: 10.1038/s41416-018-0150.
   PubMed     Text format     Abstract available
   
   
   March 2018
2. XIN L, Yang WF, Zhang HT, Li YF, et al
   The mechanism study of lentiviral vector carrying methioninase enhances the sensitivity of drug-resistant gastric cancer cells to Cisplatin.
   Br J Cancer. 2018 Mar 26. pii: 10.1038/s41416-018-0043.
   PubMed     Text format     Abstract available
   
   
   
3. SHIMADA S, Akiyama Y, Mogushi K, Ishigami-Yuasa M, et al
   Identification of selective inhibitors for diffuse-type gastric cancer cells by screening of annotated compounds in preclinical models.
   Br J Cancer. 2018 Mar 12. pii: 10.1038/s41416-018-0008.
   PubMed     Text format     Abstract available
   
   
   February 2018
4. MIKI Y, Yashiro M, Okuno T, Kitayama K, et al
   CD9-positive exosomes from cancer-associated fibroblasts stimulate the migration ability of scirrhous-type gastric cancer cells.
   Br J Cancer. 2018 Feb 13. pii: bjc2017487. doi: 10.1038/bjc.2017.
   PubMed     Text format     Abstract available
   
   
   
5. YUZHALIN AE, Urbonas T, Silva MA, Muschel RJ, et al
   A core matrisome gene signature predicts cancer outcome.
   Br J Cancer. 2018;118:435-440.
   PubMed     Text format     Abstract available
   
   
   
6. NIEMINEN MT, Listyarifah D, Hagstrom J, Haglund C, et al
   Treponema denticola chymotrypsin-like proteinase may contribute to orodigestive carcinogenesis through immunomodulation.
   Br J Cancer. 2018;118:428-434.
   PubMed     Text format     Abstract available
   
   
   January 2018
7. AJANI JA, Estrella JS, Chen Q, Correa AM, et al
   Galectin-3 expression is prognostic in diffuse type gastric adenocarcinoma, confers aggressive phenotype, and can be targeted by YAP1/BET inhibitors.
   Br J Cancer. 2018;118:52-61.
   PubMed     Text format     Abstract available
   
   
   December 2017
8. WANG X, Zhao DB, Yang L, Chi Y, et al
   S-1 chemotherapy and intensity-modulated radiotherapy after D1/D2 lymph node dissection in patients with node-positive gastric cancer: a phase I/II study.
   Br J Cancer. 2017 Dec 12. pii: bjc2017424. doi: 10.1038/bjc.2017.
   PubMed     Text format     Abstract available
   
   
   November 2017
9. FANG C, Wang W, Feng X, Sun J, et al
   Nomogram individually predicts the overall survival of patients with gastroenteropancreatic neuroendocrine neoplasms.
   Br J Cancer. 2017;117:1544-1550.
   PubMed     Text format     Abstract available
   
   
   October 2017
10. SEO AN, Kang BW, Kwon OK, Park KB, et al
    Intratumoural PD-L1 expression is associated with worse survival of patients with Epstein-Barr virus-associated gastric cancer.
    Br J Cancer. 2017 Oct 26. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available
    
    
    September 2017
11. GAYARRE J, Martin-Gimeno P, Osorio A, Paumard B, et al
    Characterisation of the novel deleterious RAD51C p.Arg312Trp variant and prioritisation criteria for functional analysis of RAD51C missense changes.
    Br J Cancer. 2017;117:1048-1062.
    PubMed     Text format     Abstract available
    
    
    
12. ALMEIDA GS, Panek R, Hallsworth A, Webber H, et al
    Pre-clinical imaging of transgenic mouse models of neuroblastoma using a dedicated 3-element solenoid coil on a clinical 3T platform.
    Br J Cancer. 2017;117:791-800.
    PubMed     Text format     Abstract available
    
    
    August 2017
13. JIMENEZ FONSECA P, Carmona-Bayonas A, Hernandez R, Custodio A, et al
    Lauren subtypes of advanced gastric cancer influence survival and response to chemotherapy: real-world data from the AGAMENON National Cancer Registry.
    Br J Cancer. 2017 Aug 1. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available
    
    
    June 2017
14. SAMARENDRA H, Jones K, Petrinic T, Silva MA, et al
    A meta-analysis of CXCL12 expression for cancer prognosis.
    Br J Cancer. 2017;117:124-135.
    PubMed     Text format     Abstract available
    
    
    
15. KUROKAWA Y, Yang HK, Cho H, Ryu MH, et al
    Phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumours of the stomach.
    Br J Cancer. 2017;117:25-32.
    PubMed     Text format     Abstract available
    
    
    
16. SIERZEGA M, Kaczor M, Kolodziejczyk P, Kulig J, et al
    Evaluation of serum microRNA biomarkers for gastric cancer based on blood and tissue pools profiling: the importance of miR-21 and miR-331.
    Br J Cancer. 2017 Jun 22. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available
    
    
    
17. ZHANG P, Tang WM, Zhang H, Li YQ, et al
    MiR-646 inhibited cell proliferation and EMT-induced metastasis by targeting FOXK1 in gastric cancer.
    Br J Cancer. 2017 Jun 20. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available
    
    
    
18. CUSTODIO A, Carmona-Bayonas A, Jimenez-Fonseca P, Sanchez ML, et al
    Nomogram-based prediction of survival in patients with advanced oesophagogastric adenocarcinoma receiving first-line chemotherapy: a multicenter prospective study in the era of trastuzumab.
    Br J Cancer. 2017;116:1526-1535.
    PubMed     Text format     Abstract available
    
    
    April 2017
19. WENNERSTROM ECM, Simonsen J, Camargo MC, Rabkin CS, et al
    Acid-suppressing therapies and subsite-specific risk of stomach cancer.
    Br J Cancer. 2017;116:1234-1238.
    PubMed     Text format     Abstract available
    
    
    March 2017
20. PETRICK JL, Kelly SP, Liao LM, Freedman ND, et al
    Body weight trajectories and risk of oesophageal and gastric cardia adenocarcinomas: a pooled analysis of NIH-AARP and PLCO Studies.
    Br J Cancer. 2017;116:951-959.
    PubMed     Text format     Abstract available
    
    
    
21. BAI T, Yokobori T, Altan B, Ide M, et al
    High STMN1 level is associated with chemo-resistance and poor prognosis in gastric cancer patients.
    Br J Cancer. 2017 Mar 23. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available
    
    
    
22. SONG Y, Wang Y, Tong C, Xi H, et al
    A unified model of the hierarchical and stochastic theories of gastric cancer.
    Br J Cancer. 2017 Mar 16. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available
    
    
    February 2017
23. WANG Z, Koh WP, Jin A, Wang R, et al
    Composite protective lifestyle factors and risk of developing gastric adenocarcinoma: the Singapore Chinese Health Study.
    Br J Cancer. 2017;116:679-687.
    PubMed     Text format     Abstract available
    
    
    
24. LIANG X, Shi H, Yang L, Qiu C, et al
    Inhibition of polypyrimidine tract-binding protein 3 induces apoptosis and cell cycle arrest, and enhances the cytotoxicity of 5- fluorouracil in gastric cancer cells.
    Br J Cancer. 2017 Feb 21. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available
    
    
    January 2017
25. LI P, Chen H, Chen S, Mo X, et al
    Circular RNA 0000096 affects cell growth and migration in gastric cancer.
    Br J Cancer. 2017 Jan 12. doi: 10.1038/bjc.2016.
    PubMed     Text format     Abstract available
    
    
    December 2016
26. KODAMA H, Murata S, Ishida M, Yamamoto H, et al
    Prognostic impact of CD44-positive cancer stem-like cells at the invasive front of gastric cancer.
    Br J Cancer. 2016 Dec 8. doi: 10.1038/bjc.2016.
    PubMed     Text format     Abstract available
    
    
    November 2016
27. OHASHI T, Komatsu S, Ichikawa D, Miyamae M, et al
    Overexpression of PBK/TOPK relates to tumour malignant potential and poor outcome of gastric carcinoma.
    Br J Cancer. 2016 Nov 29. doi: 10.1038/bjc.2016.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: